Literature DB >> 7805354

Comparative evaluation of the E test for susceptibility testing of Nocardia species.

J R Biehle1, S J Cavalieri, M A Saubolle, L J Getsinger.   

Abstract

The E Test (PDM Epsilometer; AB Biodisk, Solna, Sweden) was compared with microbroth dilution and disk diffusion for antimicrobial susceptibility testing of Nocardia as a collaborative study by two geographically separate laboratories. A total of 52 clinical isolates and five species of Nocardia were used in this comparative evaluation. Susceptibility testing was performed with Mueller-Hinton media and eight antimicrobial agents. Growth of the test strains with Mueller-Hinton medium was generally satisfactory, with the majority of isolates producing adequate growth within 24-36 h. Growth inhibition ellipses were generally well delineated and uniform for most drugs, and the points of intersection with the E Test strip were generally easy to determine. An inoculum size of approximately 2.0 x 10(7) CFU/ml was optimal for performance of the E Test method with the Nocardiae. Comparison of E Test and microbroth dilution MICs revealed 89.4% agreement for all drugs within +/- 1 log2 dilution. Using NCCLS interpretive criteria for susceptible and resistant results, complete agreement between E Test and disk diffusion results was 93.3%, and between E Test and microbroth dilution results was 96.2%. Interpretive category errors occurred at rates of 18.2% (risk corrected), 0, and 4.1% for very major, major, and minor errors, respectively, when E Test results were compared with disk diffusion results, and 0, 0, and 3.8%, respectively, when E Test was compared with microbroth dilution. Inter- and intra-laboratory reproducibility, within +/- 1 log2 dilution for all drugs, was 95% and 98%, respectively. Results from this study suggest that E Test may be suited for use as an alternative method for antimicrobial susceptibility testing of Nocardia species.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7805354     DOI: 10.1016/0732-8893(94)90120-1

Source DB:  PubMed          Journal:  Diagn Microbiol Infect Dis        ISSN: 0732-8893            Impact factor:   2.803


  18 in total

Review 1.  Nocardiosis: review of clinical and laboratory experience.

Authors:  Michael A Saubolle; Den Sussland
Journal:  J Clin Microbiol       Date:  2003-10       Impact factor: 5.948

2.  Nocardia pseudobrasiliensis as an emerging cause of opportunistic infection after allogeneic hematopoietic stem cell transplantation.

Authors:  David Lebeaux; Fanny Lanternier; Nicolas Degand; Emilie Catherinot; Isabelle Podglajen; Marie-Thérèse Rubio; Felipe Suarez; Marc Lecuit; Jean-Luc Mainardi; Olivier Lortholary
Journal:  J Clin Microbiol       Date:  2009-11-25       Impact factor: 5.948

3.  In Vitro Comparison of Ertapenem, Meropenem, and Imipenem against Isolates of Rapidly Growing Mycobacteria and Nocardia by Use of Broth Microdilution and Etest.

Authors:  Barbara A Brown-Elliott; Jessica Killingley; Sruthi Vasireddy; Linda Bridge; Richard J Wallace
Journal:  J Clin Microbiol       Date:  2016-04-06       Impact factor: 5.948

4.  Western blot monitoring of disseminated Nocardia nova infection treated with clarithromycin, imipenem, and surgical drainage.

Authors:  C Burucoa; I Breton; A Ramassamy; J Soyer; B Becq-Giraudon; J L Fauchère
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1996-12       Impact factor: 3.267

5.  In vitro activities of tigecycline and eight other antimicrobials against different Nocardia species identified by molecular methods.

Authors:  Emilia Cercenado; Mercedes Marín; Mónica Sánchez-Martínez; Oscar Cuevas; José Martínez-Alarcón; Emilio Bouza
Journal:  Antimicrob Agents Chemother       Date:  2006-12-28       Impact factor: 5.191

6.  In vitro activities of linezolid against multiple Nocardia species.

Authors:  B A Brown-Elliott; S C Ward; C J Crist; L B Mann; R W Wilson; R J Wallace
Journal:  Antimicrob Agents Chemother       Date:  2001-04       Impact factor: 5.191

7.  Antimicrobial susceptibility testing and profiling of Nocardia species and other aerobic actinomycetes from South Africa: comparative evaluation of broth microdilution versus the Etest.

Authors:  Warren Lowman; Naseema Aithma
Journal:  J Clin Microbiol       Date:  2010-10-27       Impact factor: 5.948

Review 8.  Nocardia infections among immunomodulated inflammatory bowel disease patients: A review.

Authors:  Cândida Abreu; Nuno Rocha-Pereira; António Sarmento; Fernando Magro
Journal:  World J Gastroenterol       Date:  2015-06-07       Impact factor: 5.742

9.  In vitro activity of fluoroquinolones against clinical isolates of Nocardia identified by partial 16S rRNA sequencing.

Authors:  G Hansen; S Swanzy; R Gupta; B Cookson; A P Limaye
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2007-11-09       Impact factor: 3.267

10.  Isolation of Nocardia paucivorans from the cerebrospinal fluid of a patient with relapse of cerebral nocardiosis.

Authors:  M Eisenblätter; U Disko; G Stoltenburg-Didinger; H Scherübl; K P Schaal; A Roth; R Ignatius; M Zeitz; H Hahn; J Wagner
Journal:  J Clin Microbiol       Date:  2002-09       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.